Amgen Talks Dual Pricing Strategy For Amjevita

Debut US Humira Biosimilar Has Been Priced To Address ‘Complexity Of The US Market’

 
• By David Wallace
5% 55% Pie Charts
Amgen is offering Amjevita at both 5% and 55% off Humira’s list price • Source: Shutterstock

More from Biosimilars

More from Products